BioSpace News Archive

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the quarter ended September 30, 2021.

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced that the Company will release its third quarter 2021 financial results on Tuesday, November 9, 2021, after the close of U.S. markets.

Amgen announced financial results for the third quarter of 2021.

Rigel Pharmaceuticals, Inc. reported financial results for the third quarter ended September 30, 2021, including sales of TAVALISSE® tablets for the treatment of adults with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.

Cumberland Pharmaceuticals Inc. announced that it will release third quarter 2021 financial results and provide a Company update after the market closes on Tuesday, November 9, 2021.

DURECT Corporation announced financial results for the three months ended September 30, 2021 and provided a corporate update.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced that its management will participate at the following conferences.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), today announced that management plans to present and host investor meetings at the Stifel 2021 Virtual Healthcare Conference.

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced that company management will participate in the following upcoming investor conferences.

Cerus Corporation announced financial results for the third quarter ended September 30, 2021.